Alaunos Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $71.8M
Liabilities Breakdown FY2013
Total Liabilities: $22.4M
Asset Breakdown
Total Assets: $71.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $68.2M | 95.1% |
| Accounts Receivable | $145.0K | 0.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $801.0K | 1.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.6M | 3.6% |
Liabilities Breakdown
Total Liabilities: $22.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $422.0K | 1.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $21.9M | 98.1% |